## **Core Concept**
The question tests knowledge of antimicrobial therapy, specifically for skin infections caused by Methicillin-resistant *Staphylococcus aureus* (MRSA). MRSA is a type of bacteria that is resistant to many antibiotics, including methicillin and other penicillins and penicillin-like medications. Treatment for MRSA skin infections requires antibiotics that are effective against this resistant organism.

## **Why the Correct Answer is Right**
The correct answer, , is a glycopeptide antibiotic that is effective against MRSA. It works by inhibiting cell wall synthesis in bacteria, which ultimately leads to bacterial cell death. Vancomycin is considered a drug of choice for serious MRSA infections, including skin and soft tissue infections, due to its efficacy and relatively low resistance rate among MRSA strains.

## **Why Each Wrong Option is Incorrect**
* **Option A:** - This option might represent a different antibiotic that is not effective against MRSA. Without specifying, we can infer that if it's not , it's likely incorrect because it's not the first-line treatment for MRSA skin infections.
* **Option B:** - This could represent another antibiotic that is not effective against MRSA or is used for different types of infections.
* **Option D:** - Similarly, this option would be incorrect if it represents an antibiotic that is not effective against MRSA.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that for outpatient treatment of uncomplicated MRSA skin infections, doxycycline or clindamycin may also be considered based on susceptibility testing, but for more severe infections or in cases where susceptibility is unknown, **vancomycin** is a reliable choice. Always consider local resistance patterns when choosing an antibiotic.

## **Correct Answer:** . Vancomycin